[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100659569":3},{"organization":4,"outcomesModule":7,"designInfo":39,"detailedDescription":38,"studyPopulation":38,"armGroups":45,"interventions":52,"overallOfficials":38,"centralContacts":56,"locations":38,"responsibleParty":65,"collaborators":38,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":38,"eligibilityCriteria":73,"healthyVolunteers":70,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":38,"studyType":80,"phases":81,"briefSummary":82,"conditions":83,"keywords":88,"overallStatus":93,"whyStopped":38,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":38},{"fullName":5,"class":6},"University of Kansas Medical Center","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":38},[9],{"measure":10,"description":11,"timeFrame":12},"Primary outcome is transition success (Goal: 80% of referred)","Medical record abstraction will be used to collect detailed information on each participant's cancer history and follow-up care. This process will include extraction of key clinical data such as cancer diagnosis, dates of treatment, treatment location, and specific treatment modalities, including radiation and chemotherapy doses. Additional information on relapse history, occurrence of secondary malignancies, and adherence to COG screening recommendations will also be obtained. Data on subspecialty referrals, scheduled appointment dates, and attendance at those appointments will be recorded to assess patterns of care and follow-up.","Medical record abstraction at baseline and annually for 3 years.",[14,18,21,25,29,32,35],{"measure":15,"description":16,"timeFrame":17},"Adolescent and young adult engagement and feedback","Semi-structured interviews with AYA patients will collect qualitative feedback focused on feasibility, acceptability, and utility of the program. For AYAs who do not participate in the program, interviews will inquire about barriers or reasons for non-participation.\n\nInterviews will focus on the following core topics: overall experience with pre-transition assessment and navigation, clarity and relevance of information provided, access to recommended resources and barriers, fertility education experience and referrals, self-management and transition readiness changes, suggestions to improve the program, and preferred mode\u002Ftiming of contacts.","Assessed by structured interviews at 18 & 36 mo.",{"measure":19,"description":11,"timeFrame":20},"Adherence to Children's Oncology Group (COG) survivorship guidelines.","Will be assessed by medical record abstraction at baseline, and annually for 3 years.",{"measure":22,"description":23,"timeFrame":24},"Demographic and diversity-related factors of representation","The Behavioral Measurement-Based Care in Psychiatry (BMCP) Diversity Dimensions Measurement Tool is a checklist assessing demographic and diversity-related factors to examine representation. After baseline, we will shorten this measure by only including demographic factors that have potential to change over time.","Will be assessed at baseline and years 1-3.",{"measure":26,"description":27,"timeFrame":28},"Transition Readiness","The Transition Readiness Assessment Questionnaire (TRAQ13) is a questionnaire assessing preparedness for transition to adult healthcare.","Will be measured at baseline and years 1-3.",{"measure":30,"description":31,"timeFrame":28},"Health-Related Quality of Life","National Institutes of Health (NIH) Patient Reported Outcomes Measurement Information System (PROMIS)-29+2 is a tool to measure health-related quality of life.",{"measure":33,"description":34,"timeFrame":28},"Reproductive Concerns","The Reproductive Concerns after Cancer (RCAC) scale is an instrument used to measure concerns regarding fertility and parenthood among AYA cancer survivors.",{"measure":36,"description":37,"timeFrame":28},"Economic Impact of Illness","COST-FACIT instrument quantifies the economic impact of illness from a patient's perspective (particularly in cancer care).",null,{"allocation":40,"interventionModel":41,"interventionModelDescription":38,"primaryPurpose":42,"observationalModel":38,"timePerspective":38,"maskingInfo":43},"NA","SINGLE_GROUP","SUPPORTIVE_CARE",{"masking":44,"maskingDescription":38,"whoMasked":38},"NONE",[46],{"label":47,"type":48,"description":49,"interventionNames":50},"Transitions Program","EXPERIMENTAL","Participants will receive:\n\n1. A pre-transition developmental needs assessment\n2. Up to 2 years of AYA nurse navigation support",[51],"Behavioral: Transitions Program",[53],{"type":54,"name":47,"description":49,"armGroupLabels":55,"otherNames":38},"BEHAVIORAL",[47],[57,62],{"name":58,"role":59,"phone":60,"phoneExt":38,"email":61},"Carolyn Bates, PhD","CONTACT","913-588-6323","cbates4@kumc.edu",{"name":63,"role":59,"phone":38,"phoneExt":38,"email":64},"Kari Streumph, PhD","kstruemph@kumc.edu",{"type":66,"investigatorFullName":58,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":38,"oldOrganization":38},"PRINCIPAL_INVESTIGATOR","Assistant Professor, Pediatrics","100659569","aya-cancer-transitions-program-100659569",false,"NCT07865013","AYA Cancer Transitions Program","Inclusion Criteria:\n\n1. 18-24 years of age at recruitment\n2. Referral to adult survivorship clinic\n3. Primary cancer diagnosis occurred at age 21 years or younger\n4. English language proficiency.\n\nExclusion Criteria:\n\nUndergoing active treatment for cancer or recurrence","ALL","18 Years","24 Years",{"count":78,"type":79},100,"ESTIMATED","INTERVENTIONAL",[40],"This is a single-arm, minimal-risk, interventional behavioral clinical trial embedding structured transition support for adolescent and young adult (AYA) survivors of pediatric cancer transitioning into adult-focused survivorship care. Aims are to improve AYA transition from pediatric to adult survivorship care and to enhance AYA access to fertility education and care.\n\nPatient Participants will:\n\n1. Complete a pre-transition developmental needs assessment\n2. Receive up to 2 years of AYA nurse navigation support",[84,85,86,87],"Cancer","Cancer Survivorship","Adolescent and Young Adult Cancer Survivors","Transitions of Care",[84,89,90,91,92,85],"Adolescent","Young Adult","AYA","Transitions of care","NOT_YET_RECRUITING","2026-10-02",{"date":96,"type":97},"2026-10-08","ACTUAL",{"date":99,"type":79},"2027-01",{"date":101,"type":79},"2030-12",{"name":5,"class":6}]